With the gradual transformation of China's pharmaceutical business to an open economy, the small-scale drug distribution model is rare in the past. In Jiangsu, Hubei, Shandong and other provinces, many pharmaceutical commercial companies often use the network of social third-party logistics companies to send a large number of drugs to all parts of the country. The author believes that this pharmaceutical commercial sales model of batch import and export and off-site deployment will be popular in the domestic market in the future.
However, with the development of pharmaceutical commercial distribution business, the third-party logistics in turn restricts the development of pharmaceutical distribution business. As we all know, medical logistics not only has the circulation characteristics of ordinary goods, but also has special requirements for logistics links because of the particularity of drug storage. In addition, medical distribution is characterized by the batch distribution of high-value drugs in different places, and the high value of goods also puts forward higher requirements for the service ability and security of third-party logistics. However, at present, the overall service level of third-party logistics in China can not meet the development needs of pharmaceutical commercial distribution business.
The quality of service needs to be improved.
China's professional third-party pharmaceutical logistics enterprises only started to operate in 2004, and the qualification certification of pharmaceutical logistics enterprises only started in some developed provinces in East China in 2006. Due to the late start, there is not a professional third-party medical logistics provider in China that can cover the whole country. Therefore, the distribution and sales of goods in most pharmaceutical commercial companies can only be realized by freight companies that are popular in society and mainly meet the circulation of ordinary goods. However, due to the different characteristics of the industry, it is difficult for ordinary freight companies to meet the needs of pharmaceutical companies, and the service quality needs to be improved urgently. For example, the drugs prepared by pharmaceutical business are often products with obvious price differences between the two sides, so the timeliness of preparation is very high. But at present, the average time for domestic third-party logistics enterprises to distribute drugs is 3~5 days; However, the transportation price of logistics companies that can realize the national circulation of drugs within two days (except in remote provinces such as Xinjiang, Inner Mongolia, Gansu, Heilongjiang and Tibet) is prohibitive. In addition, for drugs that need to be refrigerated, it is generally difficult for social logistics companies to realize the whole low-temperature distribution of drugs if they want to be distributed to county-level markets. It can be seen that there is still a big gap between the logistics service level of the third-party logistics companies in the society and the needs of enterprises.
It is difficult to solve the problem of payment recovery.
The value of most single transfer business of medical transfer orders is very high, especially cross-provincial transfer orders, and some single transactions even exceed one million yuan. This kind of large transaction is usually cash on delivery, but there are still some transfer businesses below tens of thousands of yuan that are cash on delivery. The recovery of these funds is a major problem in the transfer business of commercial companies.
Generally speaking, pharmaceutical commercial companies will not easily let social third-party logistics companies collect money. This is because the phenomenon of "evaporation" of payment in China's highway logistics and distribution industry is more serious: at the beginning of this year, the boss of "Integrity Freight Department" in Donghuan Wholesale Market of Yinchuan City, Ningxia swept away more than 370,000 yuan of payment from dozens of merchants in the market; Coincidentally, in Shandong Province, Guowei Logistics Company, headquartered in Linyi, left the building empty after taking millions of dollars in payment from customers.
The deep-seated reason of this kind of cases is that the threshold for setting up freight companies in China is too low and the constraints are insufficient. It is reported that under normal circumstances, as long as the name declared by the applicant of the freight department is not duplicate with the existing freight department in the market, it can pass the examination and approval, and the requirements for the applicant's capital, own vehicles and other hardware standards that can prove its strength are not high. Therefore, once the freight department or the so-called freight company itself has economic risks, it is difficult to guarantee the interests of the entrusted merchants. In this case, pharmaceutical commercial enterprises naturally dare not easily hand over the "payment back" business to logistics enterprises, which further restricts the further development of the deployment business.
Develop in the norm
It should be said that the expansion of pharmaceutical business needs the support of third-party logistics; The expansion of the third-party logistics business needs to continuously expand the service field. Therefore, to solve the problem that the service level of social third-party logistics can not meet the demand of medical commercial distribution, all parties need to work together.
The author believes that on the one hand, the government should formulate more reasonable and perfect policies to regulate the market. For example, appropriately raise the registration threshold of third-party logistics enterprises, increase the cost of enterprise dishonesty, and guide powerful logistics enterprises to become bigger and stronger. Logistics industry associations can implement special service access system and payment collection access system in this industry, stipulating that only logistics enterprises with a certain scale and credit level can enter the pharmaceutical industry and carry out payment collection business. It should be emphasized that trade associations should collect part of the accident deposit and integrity deposit.
On the other hand, relevant government departments should also actively explore and promote the access system of professional pharmaceutical logistics enterprises, encourage excellent logistics companies and pharmaceutical commercial companies to obtain professional pharmaceutical logistics qualifications, and realize the docking of different industry regulations.
As a pharmaceutical commercial company, it also needs to strengthen the awareness of standardized management. The author sees that the third-party logistics service providers of many pharmaceutical commercial companies are individual freight forwarders or the freight department of individual merchants. Neither party has even signed a freight contract, and they only rely on the personal friendship between the transportation supervisor and the other company to carry out their business. In this way, in the event of an accident, there is basically no possibility of claiming compensation. Therefore, pharmaceutical commercial companies should also pay attention to standardized operation, choose reliable logistics enterprises and minimize market risks, so as to make a difference in the allocation of consignment business.